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Abstract
With the shift of molecular technologies directed toward the understanding of
greater biological complexity of the oral cavity, a knowledge gap was created by the
lack of genomic data from the diverse oral microorganisms. To facilitate and enable
the interpretation of metagenomic, transcriptomic, and proteomic data generated
or soon to be generated from oral biofilms, we are providing reference genomic
information from phylogenetically diverse oral bacterial isolates. This work, initiated
by the National Institute of Dental and Craniofacial Research as an isolated effort,
is now part of the Human Microbiome Project. The goal of this effort is the public
release of genomic data in support of functional and phylogenetic analyses of the
complex oral microbiome. The genomic information acquired will be a key component in understanding the interaction of the oral biofilms with the human host
and in developing novel healthcare strategies to prevent and treat oral diseases.
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Introduction
The human oral biofilms are readily accessible complex bacterial communities. Although it is one of the best-characterized microbiomes at
the phylogenetic level, its internal dynamics and relationship to the
host remain a mystery. This abundant self-renewable biofilm is responsible for oral health as well as diseases of both hard and soft tissues
of the oral cavity. In addition, evidence is accumulating to indicate the
microbiome’s significant influence on overall health, through a direct
interactive exchange between the host response and the members of
the oral microbiome [1–3]. Bacterial complexes are involved in those
processes, and no individual pathogen can be singled out [4–7].
Bacterial diversity is a key characteristic of dental sub and supragingival plaque as well as the biofilms on other oral surfaces including the gingiva, tongue, hard palate, and cheeks. To date, over 600
bacterial species and a single archaea species have been identified as
members of the oral community [5, 8, 9]. This number is increasing as
more studies are performed all over the world. The added diversity
may be related to disease status, regional environmental factors, or
diet. For example, one might expect that the oral flora of a subject
with a diet rich in raw fish with high fatty acid content will differ from
the flora of a vegan subject. Such population changes have been well
demonstrated in subjects with periodontitis compared with healthy
subjects [4, 6, 10]. This underscores the interplay between the bacterial
members of the oral biofilms, the host’s physiological reactions and
the fact that the mouth is an open system to the environment. Foods
and fluids that we ingest as well as air that we breathe are significant
sources of new bacterial challenges on a daily basis.
The extent of the morphological diversity of the bacteria in the
oral cavity is astonishing. The highly motile spiral of the treponemes
might coexist with the gliding multicellular-filamentous species of
the genus Simonsiella, the corncob arrangements of Corynebacterium
matruchotii or Fusobacterium nucleatum with Streptococcus sanguis,
as well as cocci, short and long rods [11–14]. The phylogenetic diversity encompasses at least 12 phyla and over 170 genera [8]. The
genera include cultivable named species (47%), cultivable yet-to-benamed species (18%), and yet-to-be-cultivated phylotypes, which often wear the inaccurate label of uncultivable in the literature (35%).
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These numbers are always fluctuating as the naming of organisms
is an ongoing process [14, 15], and novel culture methods are being
developed.
The variety of organisms, mentioned above, results in a diverse
genetic potential that is mostly untapped and unknown. How those
bacteria produce pathogenic factors, resist antibiotics, evade host immune response, communicate with each others, or simply use nutrients for their own energy production is mostly a mystery. The genetic
characteristics of these oral bacteria are unknown because most of
them are considered commensal and have not been the focus of many
studies. Other factors detrimental to their study are their fastidious
growth characteristics compared to Escherichia coli or Bacillus subtilis
and their lack of established genetic systems.
While metagenomics, transcriptomics, and proteomics are part of
the next key steps of understanding complex systems, they all rely on
availability of the genomic sequence to decipher the content of the
dataset via similarities to better known systems. These similarities provide the original clues toward function and phylogenetic attribution.
With the absence of such data for most of the oral microbiome members, the scientific community was likely at risk to miss some of the
benefits from the ongoing technological advances in the omic world.
Those advances touch all aspects of fields looking at a large-scale
analysis of a genome, a proteome, or a metabolome, just to name a
few. Prior to joining the Human Microbiome project, we provided genome surveys to the community (Table 1). Genome surveying is a low
cost approach to provide anchoring genetic data for metagenomic
analysis of obscure branches of the phylogenetic tree. Genetic libraries
were created, and 12 organisms from 6 phyla were sequenced (Table
1). A minimum of 350,000 bases were recovered and annotated per
genome (Table 1). A novel annotation pipeline was created to accommodate the short contigs generated by low sequencing coverage of
random genomic libraries (Dewhirst et al. unpublished data) [8, 15].
This took advantage of the lengths of the singlets (single sequencing
read) and the contigs (assembly of two or more sequencing reads)
that may not cover the full length of the open reading frame but are
sufficient to ascertain similarities and to provide matching sequences
to pyrosequencing generated short reads. The dynamic annotation,
updated periodically, for each genome survey is available online at
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Table 1. Genome survey data produced and released in Genbank
						
				
Taxon SEQF
Phylum
Genus
Species
Strain
IDa
IDb

No. of
Combined Genbank
contigs
length
accession
& singlets (Kbp)
number

Bacteroidetes
Prevotella
sp. oral taxon 302 F0020
302
1,020 404
Firmicutes
Bulleidia
extructa
W1219
603
1,088 350
Firmicutes
Eubacterium
infirmum
ATCC 700433
105
1,108 413
Firmicutes
Solobacterium moorei
W5408
678
1,152 338
Firmicutes
Veillonella
parvula
ATCC 17745
161
1,058 353
Fusobacteria
Leptotrichia
buccalis
ATCC 14201
563
1,028 345
Proteobacteria
Campylobacter gracilis
ATCC 33236
623
1,005 384
Proteobacteria
Campylobacter rectus
ATCC 33238
748
1,089 356
Proteobacteria
Campylobacter showae
ATCC 51146
763
1,091 352
Spirochaetes
Treponema
lecithinolyticum
OMZ 684T
653
1,060 1,377
Synergistetes
Jonquetella
anthropi
E3_33 E1
777
1,476 509
Synergistetes
Pyramidobacter piscolens
W5455
357
1,541 852
						Total

362
385
409
354
372
392
402
353
340
1,469
618
615
6,033

FI090687-FI091098
ET629122-ET629476
ET630587-ET631005
ET631874-ET632213
ET632214-ET632569
ET631526-ET631873
ET629477-ET629866
ET629867-ET630228
ET630229-ET630586
ET632570-ET633946
ET631006-ET631525
DU723013-DU723395

a. Taxon ID refers to a phylotype designation as part of the investigation of phylogenetic diversity of the oral microbiome,
http://www.homd.org
b. SEQF ID is a unique identifier of bacterial genomes sequenced from a unique isolate from a specific laboratory
http://www.homd.org

the Human Oral Microbiome database (http://www.homd.org) [8]. The
manual annotation of Pyramidobacter piscolens genome survey data
was published when the organism was named [16].
With the announcement of the Human Microbiome Project, another
era of bacterial genome sequencing began [17]. Becoming a member
of this scientific endeavor allowed the transition from the production
of genome surveys to the sequencing of full genomes by pyrosequencing. This is being done in partnership with four genomic centers:
the Broad Institute of MIT and Harvard, the J. Craig Venter Institute,
the Genome Sequencing Center at Washington University, and the
Human Genome Sequencing Center at the Baylor College of Medicine.
Now, with the first 50 bacterial genomes provided to the centers for
sequencing, we look forward to closing the gap in describing genetic
and phylogenetic diversity. The progress done can be monitored at
the Human Microbiome Project website (http://www.hmpdacc.org)
and at the Human Oral Microbiome database. In addition, the bacterial strains are provided to the Biodefense and Emerging Infections
Research Resources Repository at ATCC (http://www.beiresources.org)
for availability to the scientific community at large. For phylogenetic
studies, the essentially full sequences of the 16S ribosomal RNA gene
are also provided to GenBank repository.
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How will this benefit the patient? With the acceptance that oral
bacteria are part of the equation for good oral health, it becomes important to ensure that day-to-day treatments (toothpastes, oral rinses,
etc.) are not damaging the host immune response or suppressing of
the most critical group of bacteria involved in oral health. Moving
toward prevention requires an unprecedented effort to understand
what health is. It is also important to understand what the organisms’ proportions are, which bacterial complexes are prevalent, which
metabolic pathways are shared, which part of the genomic potential is
expressed (transcriptomics), what the composition of a bacteria in the
biofilm (proteomics) is, and consequently which abundant potential
peptide targets are available for drug design and which metabolites
are released (metabolomics) and could be targets for inhibitors. Genetic studies of both the normal and the pathogenic flora will be, as
they have been in the past, a key element to develop drug therapies
[18, 19]. Discovering the components contributing to health at the
microbiome level can lead to clinical strategies to maintain a healthy
balance between the microbiome and the host response.
The next steps are for the scientific community to expand the work
of isolating new strains and providing genomic sequence information. This process will improve our ability to understand how the oral
microbiome self-organizes and interacts with the host. This host interaction is a key component in the dynamic interplay, leading to the
maintenance of oral health as well as the population shifts resulting
in chronic diseases such as caries and periodontitis. Increased understanding of the behavior of the oral biofilms through transcriptomics,
proteomics, interactomics, functomics, and many other “omic” disciplines relies on the available genomic data, and will open new avenues
for treatment strategies.
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